(Q39625657)
Statements
1 reference
MEK1/2 inhibitors AS703026 and AZD6244 may be potential therapies for KRAS mutated colorectal cancer that is resistant to EGFR monoclonal antibody therapy (English)
1 reference
Kang-Yell Choi
1 reference
Juyong Yoon
1 reference
Kyoung-Hwa Koo
1 reference
30 November 2010
1 reference
1 reference
71
1 reference
2
1 reference
445-453
1 reference
Identifiers
1 reference
1 reference